Selected article for: "meta analysis and sensitivity analysis"
Author: Furong Zeng; Ying Guo; Mingzhu Yin; Xiang Chen; Guangtong Deng
Title: Association of inflammatory markers with the severity of COVID-19
  • Document date: 2020_4_17
    • ID: mn3b6nrs_25
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10. 1101 Health Commission of China, decreasing level of IL-6 indicates the deterioration of COVID-19. Our study firstly provided an evidence-based medicine evidence through meta-analysis. Moreover, the level of IL-6 could not be routinely detected in many hospitals of China, but some inflammatory markers such as CRP, PCT and ESR usually could be detected. O.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10. 1101 Health Commission of China, decreasing level of IL-6 indicates the deterioration of COVID-19. Our study firstly provided an evidence-based medicine evidence through meta-analysis. Moreover, the level of IL-6 could not be routinely detected in many hospitals of China, but some inflammatory markers such as CRP, PCT and ESR usually could be detected. Our study firstly put forward that besides IL-6, other inflammatory markers such as CRP, PCT and ESR were also positively correlated with the severity of COVID-19. These conclusions were consistent through sensitivity analysis and publication bias assessment.

    Search related documents:
    Co phrase search for related documents
    • China hospital and inflammatory marker: 1
    • China hospital and level decrease: 1, 2, 3
    • China hospital and medicine evidence: 1
    • China hospital and meta analysis: 1
    • China hospital and sensitivity analysis: 1, 2, 3, 4, 5, 6, 7
    • China hospital and severity correlate: 1
    • deterioration indicate and meta analysis: 1
    • ESR PCT crp and inflammatory marker: 1
    • ESR PCT crp and meta analysis: 1, 2, 3, 4
    • evidence base and medicine evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • evidence base and meta analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
    • evidence base and publication bias: 1, 2, 3, 4
    • evidence base and sensitivity analysis: 1, 2, 3, 4, 5, 6
    • inflammatory marker and level decrease: 1
    • inflammatory marker and meta analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • inflammatory marker and publication bias: 1, 2
    • inflammatory marker and sensitivity analysis: 1, 2
    • level decrease and medicine evidence: 1
    • level decrease and meta analysis: 1, 2, 3, 4